|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Fixed maturities | ||||||||||||||||||||
| Held to maturity, at amortized cost (fair value $754,765,403 and $731,659,323; net of allowance for expected credit losses of $1,306,225 and $1,312,903) | ||||||||||||||||||||
| Available for sale, at fair value (amortized cost $650,458,942 and $650,370,011) | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Short-term investments, available for sale | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Premiums receivable | ||||||||||||||||||||
| Reinsurance receivable (net of allowance for expected credit losses of $390,961 and $374,883) | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Accounts receivable - securities | ||||||||||||||||||||
| Federal income taxes recoverable | ||||||||||||||||||||
| Due from affiliate | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Losses and loss expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Reinsurance balances payable | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Cash dividends declared to stockholders | ||||||||||||||||||||
| Federal income taxes payable | ||||||||||||||||||||
| Accounts payable - securities | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total other | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock, $.01 par value, authorized 2,000,000 shares; none issued | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Common Class A | ||||||||||||||||||||
| Common Class B | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
